Facebook
Toll-free:1-888-852-8623

All categories

  • All categories
  • Flow Cytometry Antibodies
  • Immunoassays
  • Antibodies and Reagents
  • Cell Health and Metabolism Assay Kits
  • Cell Isolation Products
  • Cell Identification Kits
  • Proteins and Peptides
  • Cell Culture
Please enter the item number/product keyword!
Keyword cannot be empty !
INSERT SYMBOLS:
  • α
  • β
  • γ
  • δ
  • ε
  • ζ
  • η
  • θ
  • κ
  • μ
  • ω
  • σ
  • τ
  • λ
  • ⅩⅢ
  • ⅩⅢ
  • ⅩⅣ
  • ⅩⅤ
  • ⅩⅦ
  • ⅩⅧ
  • UP ↑

Cell Death Atlas: A Holistic View of Cell Death Pathways

Source: Elabscience®Published: May 20,2026

Broadcasted live on June 18, 2026 - Now Streaming on Demand! 

Cell death is no longer viewed as a singular biological endpoint-it is an interconnected signaling architecture governing survival, adaptation, stress response, and programmed collapse. From apoptosis and ferroptosis to pyroptosis and emerging non-canonical pathways, molecular crosstalk orchestrates cellular decisions with remarkable precision. 

Explore the architecture of cellular fate and discover how the integration of diverse death programs is reshaping modern biomedical research.

What the Atlas Reveals 

● Cell death crosstalk across apoptosis, ferroptosis, pyroptosis, and emerging pathways

● Mechanisms driving convergence and integration of cell death networks

● Dynamic control of cellular fate in stress and disease

● Translational applications in therapeutics and disease biology

Have Questions?

Contact with our scientific team: events@elabscience.com

Speaker

Cell Death Atlas: A Holistic View of Cell Death Pathways-1

Dr. Sundas R. Qureshi

Global Scientific Liaison

Elabscience® Bionovation Inc.

Dr. Qureshi operates at the forefront of life science innovation, connecting scientific strategy with real-world application to translate complex biological systems into practical research solutions. Her expertise spans cell biology, immunology, and signaling, with a focus on cell death regulation, pathway crosstalk, and mechanistic networks in disease progression. She works closely with researchers and partners worldwide, leading international scientific trainings and engagements that support stronger experimental decisions, technology adoption, and translational outcomes. With a global presence in scientific communication and research enablement, she brings clarity, technical insight, and strategic direction to modern life science discovery.